The HinduIndia
Group questions Trehan’s role on pharma marketing panel
An advocacy group has asked India’s Department of Pharmaceuticals to remove Medanta chairman and managing director Naresh Trehan from a panel examining drug marketing practices, arguing the role could create conflicts of interest and calling for an independent replacement.
This card is an AI-assisted summary of reporting published by The Hindu. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.